GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (OTCPK:AFTPF) » Definitions » Other Long Term Assets

AFT Pharmaceuticals (AFT Pharmaceuticals) Other Long Term Assets : $1.37 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is AFT Pharmaceuticals Other Long Term Assets?

AFT Pharmaceuticals's other long-term assets for the quarter that ended in Mar. 2024 was $1.37 Mil.

AFT Pharmaceuticals's quarterly other long-term assets increased from Mar. 2023 ($2.78 Mil) to Sep. 2023 ($5.89 Mil) but then stayed the same from Sep. 2023 ($5.89 Mil) to Mar. 2024 ($1.37 Mil).

AFT Pharmaceuticals's annual other long-term assets increased from Mar. 2022 ($1.90 Mil) to Mar. 2023 ($2.78 Mil) but then declined from Mar. 2023 ($2.78 Mil) to Mar. 2024 ($1.37 Mil).


AFT Pharmaceuticals Other Long Term Assets Historical Data

The historical data trend for AFT Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals Other Long Term Assets Chart

AFT Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only 0.43 0.52 1.90 2.78 1.37

AFT Pharmaceuticals Quarterly Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.90 2.22 2.78 5.89 1.37

AFT Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


AFT Pharmaceuticals (AFT Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.

AFT Pharmaceuticals (AFT Pharmaceuticals) Headlines